摘要
目的评价微创经椎间孔入路腰椎间融合术(MIS-TLIF)治疗高位腰椎间盘突出症的中短期临床疗效。方法对自2009-01—2012-12收治的高位腰椎间盘突出症22例行MIS-TLIF术,根据患者症状、体征及影像学资料,切除单侧减压、对侧潜行减压或两侧开窗减压,并行自体及同种异体骨椎间植骨、椎间融合器融合、经皮椎弓根钉内固定。结果所有患者获平均(12±3)个月的随访,出现椎间植骨不融合1例,椎间植骨融合时间为(7.2±1.3)个月。术后下肢放射痛VAS评分及腰背痛ODI评分与术前比较,差异有统计学意义(P<0.05)。改良MacNab标准评价优良率为86.4%。结论 MIS-TLIF治疗高位腰椎间盘突出症是安全、有效的方法。
Objective To compare the short-midterm result of minimally invasive transforaminal lumbar interbody fusion （MIS-TLIF） in treatment of upper lumbar disc herniation. Methods From January 2009 to December 2012, 22 upper lumbar disc herniation patients were enrolled in the research and they were treated with minimally invasive transforaminal lumbar interbody fusion. Results All patients were followed up （12±3）months on average. There were significant difference between preoperative state and postoperative state of VSA score of leg pain and ODI score of back pain. Nonunion occurred in one ease of interbody fusion, other cases achieved union in 7.2 months on average without other complications. Conclusion The method of minimally invasive transforaminal lumbar interbody fusion in treatment of upper lumbar disc herniation is safe and effective.
出处
《中国骨与关节损伤杂志》
2014年第3期224-226,共3页
Chinese Journal of Bone and Joint Injury
关键词
高位腰椎间盘突出症
经椎间孔腰椎体间融合术
微创
Upper lumbar disc herniation
Transforaminal lumbar interbody fusion
Minimally invasive
